Home / Biopharma (page 3)

Biopharma

AbbVie Inc. (NYSE:ABBV)- Safe Haven Investment Portfolio Stocks: ImmunoGen, Inc. (NASDAQ:IMGN)

AbbVie Inc. (NYSE:ABBV) runs in leading trade, it are rising 0.23% to traded at $61.28. ABBV attains analyst recommendation of 2.50 on scale of 1-5 with week’s performance of -2.42%. To find out the technical position of ABBV, it holds price to book ratio of 15.44 that unearth high-growth companies …

Read More »

AstraZeneca PLC (NYSE:AZN)- Stocks Flirting with Minor Gains and Losses: Peregrine Pharmaceuticals (NASDAQ:PPHM)

Under investment valuation analysis, AstraZeneca PLC (NYSE:AZN) presented as an active mover, it has floated short ration of 0.79%, hold to candle to sentiment indicator of Short Ratio, which was 2.66. Shares knocked up 0.21% to trade at $28.24 in most recent trading session. Investment bank Credit Suisse kicked off …

Read More »

Abbott Laboratories (NYSE:ABT)- Most Bizarre Stocks for the Day: TherapeuticsMD, Inc. (NYSE:TXMD)

Abbott Laboratories (NYSE:ABT) keeps its position active in context of investors’ investment valuation, price per shares fell -0.88% to $40.72 with volume of 8.63 Million. Abbott (ABT) reported that U.S. launch and the first commercial uses of the new EnSite Precision™ cardiac mapping system and Advisor™ FL Circular Mapping Catheter, …

Read More »

Healthcare Stocks Getting Investors Vote of Confidence: Novavax, Inc. (NASDAQ:NVAX), Novo Nordisk A/S (NYSE:NVO)

Novavax, Inc. (NASDAQ:NVAX) also run on active notice, stock price rose 7.41% after traded at $1.45 in most recent trading session.  Novavax, Inc. (NVAX) recently reported that management will present at the 35th Annual J.P. Morgan Healthcare Conference on Thursday, January 12, 2017 at 9:30 am U.S. Pacific Time. NVAX …

Read More »

Bristol-Myers Squibb (NYSE:BMY)- Stocks Retreating on New Evolution: Express Scripts (NASDAQ:ESRX)

Bristol-Myers Squibb Company (NYSE:BMY) kept active in under and overvalue discussion, BMY holds price to book ratio of 6.08 that presents much better indicator to find market price of a share price over its book value of equity for investment valuation. In addition, the firm has price to earnings ratio …

Read More »

Stocks Defying Gravity: Teva Pharmaceutical Industries (NYSE:TEVA), Horizon Pharma (NASDAQ:HZNP)

To persist focus on investment valuation, Teva Pharmaceutical Industries Limited (NYSE:TEVA) also have significant role in eyes of active investors, firm has price to earnings growth of 9.30, which is a valuation metric for determining relative trade-off among price of a stock. Effective Investment Valuation TEVA has price to earnings …

Read More »

Healthcare Stocks Showcasing Bullish Rally: Eli Lilly and Company (NYSE:LLY), Thermo Fisher Scientific Inc. (NYSE:TMO)

Eli Lilly and Company (NYSE:LLY) keeps its position active in context of investors’ investment valuation, price per shares shows upbeat performance surged 2.51% to $77.15 with volume of 11.9 Million. Valuation of Investment Looking forward to the ratio analysis, the co has price to earnings ratio of 32.68, which is …

Read More »

Allergan plc (NYSE:AGN)- Stocks Getting Stung by Profitability Assessment: Achillion Pharmaceuticals (NASDAQ:ACHN)

Allergan plc (NYSE:AGN) persists its position slightly strong in context of buying side, while shares price inching up remains unchanged during latest trading session. Allergan plc (AGN) reported that it intends to release fourth quarter and full year 2016 financial results on Wednesday, February 8, 2017, prior to the open …

Read More »

Stocks Faring Away From Broker’s Choice: Eli Lilly and Company (NYSE:LLY), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)

Eli Lilly and Company (NYSE:LLY) [Trend Analysis] attempts to attain leading position in street, Shares price changes as it -1.32% to close at $75.26 with the total traded volume of 7.7 Million shares. Fundamentalist can give brighter side of a picture but an analyst can glow the darker parts stored …

Read More »